All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves new ocular surface anesthesia gel ➤ New drop approved to reduce IOP ➤ Newly available IOL incorporates technology that minimizes visual disturbances ➤ Interim data from Phase 1 trial for intravitreal implant to treat AMD ➤ Multiparty financing solution brought to ophthalmic practices ➤ Complimentary access to video journal ➤ ASCRS news and events
The Light Adjustable Lens is still a relatively new technology, offering the ability to adjust the refractive settings of the lens after implantation with “lock-in” treatments. Several ophthalmologists discussed their decision to bring it into practice, implementation considerations, and overall impressions.
EyeWorld spoke to two physicians for a primer on interpreting OCT of the macula and optic nerve in preparation for cataract surgery.
Two experts discussed the important topic of identifying astigmatism prior to cataract surgery: how to determine the level of astigmatism, when to address it, and how even low levels may have an impact.
A study conducted at the Madurai regional Aravind Eye Care System (AECS) hospital found that adopting Western OR protocols did not lower endophthalmitis rates following cataract surgery as compared to AECS’s standard protocols.
➤ New device for bladeless goniotomy ➤ FDA approves the first at-home digital vision test ➤ Alcon to acquire Aerie Pharmaceuticals ➤ Study: Phase 2 trial for investigational dry eye therapy meets primary endpoint ➤ ASCRS news and events
➤ Long-term safety, efficacy data reported from standalone MIGS procedure ➤ Positive clinical data in ongoing trial for investigational thyroid eye disease treatment ➤ Bioengineered cornea restores vision in 20 people ➤ ASCRS news and events
➤ FDA approves first standalone MIGS device ➤ Phase 3 clinical study results for inflammation, pain management nanosuspension ➤ Phase 2a clinical trial begins for investigational MGD treatment ➤ Registry created to collect data on canaloplasty ➤ ASCRS news and events
➤ FDA approves new multifocal IOL ➤ FDA approves new biosimilar ➤ First patient dosed in Phase 3 trial for investigational dry eye drug ➤ First patient dosed in Phase 2 trial investigating sustained delivery for wet AMD ➤ First patient dosed in Phase 2 study of small molecule to treat diabetic retinopathy ➤ Enrollment complete in Phase 3 trials evaluating myopia progression therapy ➤ Study emphasizes need for earlier glaucoma screening in black patients ➤ Company acquires diagnostic technology ➤ ASCRS news and events
➤ Phase 3 trial investigating inflammation, pain management after cataract surgery ➤ Positive topline data in study for RP gene therapy ➤ Study: Intravitreal cancer drug found to preserve vision more than traditional therapy ➤ Several studies show efficacy of home-based OCT ➤ Company announces expense reduction and refocus plan ➤ ASCRS news and events